EICHORCondition: Atopic Dermatitis · Sponsor: Sanofi
This was a parallel treatment, Phase 2, double-blind, 2-arm, placebo-controlled study with 2 staggered cohorts (2 arms in each cohort) to evaluate the efficacy and safety of rilzabrutinib in adult participants (aged at least 18 years) with moderate-to-severe AD and intolerance or inadequate response to topical corticosteroids (TCS). The total study duration per participant was expected to be approximately 21 weeks, including up to 4 weeks of screening, 16 weeks of on-treatment double-blind period, 1 week of post-treatment follow-up.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Antelope Valley Clinical Trials Site Number : 8400001 | Northridge, California, United States | — |
| Asthma and Allergy Associates, PC Site Number : 8400008 | Colorado Springs, Colorado, United States | — |
| Florida International Research Center Site Number : 8400002 | Miami, Florida, United States | — |
| Skin Sciences, PLLC Site Number : 8400005 | Louisville, Kentucky, United States | — |
| DS Research of Kentucky, LLC Site Number : 8400004 | Louisville, Kentucky, United States | — |
| Integrative Skin Care of MS/SKYCRNG Site Number : 8400011 | Ridgeland, Mississippi, United States | — |
| National Allergy and Asthma Research, LLC. Site Number : 8400007 | North Charleston, South Carolina, United States | — |
| Orion Clinical Research Site Number : 8400003 | Austin, Texas, United States | — |
| E.P.I.M.R.D dba Western Sky Research, Inc. Site Number : 8400009 | El Paso, Texas, United States | — |
| Investigational Site Number : 1240008 | Red Deer, Alberta, Canada | — |
| Investigational Site Number : 1240013 | Greater Sudbury, Ontario, Canada | — |
| Investigational Site Number : 1240001 | London, Ontario, Canada | — |
+ 19 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05018806